NRC draft guidance may complicate patient access to cancer treatment

August 18, 2023, 8:53AMNuclear News

A Nuclear Regulatory Commission draft regulatory guide—DG-8061, “Release of Patients Administered Radioactive Material”—proposes guidance on the release of patients after a medical procedure involving the administration of radiopharmaceuticals or the implantation of a sealed source. The guidance is intended to help licensees interpret NRC regulations designed to protect the people—family, friends, caregivers, or members of the general public—who may be in proximity to a patient who is discharged after receiving nuclear medicine treatment.

To continue reading, log in or create a free account!

Related Articles

NRC adopts ROP updates

March 30, 2026, 3:14PMNuclear News

The Nuclear Regulatory Commission has approved a significant overhaul of its Reactor Oversight Process (ROP) baseline inspection program that stresses a leaner, more risk-focused inspection...

U.S. Air Force opens power reactor RFI

March 30, 2026, 9:35AMNuclear News

The U.S. Air Force wants to hear from companies that could be interested in deploying small nuclear reactors at its bases.The request for information posted Wednesday intends to assist the...

NRC unveils Part 53 final rule

March 26, 2026, 7:01AMNuclear News

The Nuclear Regulatory Commission has finalized its new regulatory framework for advanced reactors that officials believe will accelerate, simplify, and reduce burdens in the new reactor...